Virtech Bio, Inc.
BEVERLY, MA · Founded 2013 · CIK 0001677847 · Medtech · Private
VIR-VET, a cell-free hemoglobin resuscitation fluid with oxygen-carrying and plasma expansion properties for hemorrhage treatment
virtechbio.com →- Grants
- $626K
- 3 awards
- Sector median: 1
- Raised
- $500K
- 1 Form D · Jun 2016
- 124 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 9
- 2 granted · 7 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2015201620172018
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $500,000 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase I · Human-derived hemoglobin based oxygen carrier for utilization in organ and tissue preservation | $238,970 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase I · Human-derived hemoglobin based oxygen carrier for utilization in organ and tissue preservation | $238,970 | |
| Federal grant | Department of Defense · Phase I · Enhanced Canine Performance, Protection and Survivability | $148,088 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 826 | MelioLabs Inc. | — | $4.0M |
| 827 | Tetrous, Inc. | — | $2.2M |
| 828 | Sonex Health, Inc. | — | $22M |
| 829 | Virtech Bio, Inc. | — | $500K |
| 830 | 149 MEDICAL INC | — | $450K |
| 831 | AMORPHEX THERAPEUTICS HOLDINGS INC. | — | $265K |
| 832 | Neural Dynamics Technologies LLC | — | $240K |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Joseph TuckerExecutive Officer
- Matias VidalDirector · Executive Officer
Patents
- Blood Substitutes Comprising Hemoglobin And Methogs Of Makinggranted
- Compositions and Methods for Treating Hemorrhagic Shockapplication
- Blood Substitutes Comprising Hemoglobin And Methods Of Makinggranted
- Oxygenation Media For Ex-vivo Preservation Of Organs And Tissuesapplication
- Oxygenation Media For Ex-vivo Preservation Of Organs And Tissuesapplication
- Blood Substitutes Comprising Hemoglobin And Methods Of Makingapplication
- Compositions And Methods For Treating Hemorrhagic Shockapplication
- Compositions And Methods For Treating Hemorrhagic Shockapplication
- Oxygenation Media For Ex-vivo Preservation Of Organs And Tissuesapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.